Novo Nordisk was eager to acquire the biotech company Metsera, but the company's board recommends the shareholders to agree to a deal with Novo's competitor, Pfizer, instead. (Archive photo). Photo: Mads Claus Rasmussen/Ritzau Scanpix
“Biotech firm picks Pfizer over Novo after bidding war”
The board of Metsera has accepted Pfizer’s offer to acquire the biotech company, advising investors to do the same, despite an initial competing bid from Danish Novo Nordisk. A press release from Metsera explains Pfizer’s offer as less legally risky compared to Novo Nordisk’s proposal. Novo...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.